Early Access — free while we kick the tires
EdgarHawk

Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Officer
1 filing analyzed · 1 company · Latest 2026-01-15

Companies

Company Buys Sells Direction
Olema Pharmaceuticals, Inc. OLMA 0 2 Net selling

Activity

January 2026
high
Sell
103,822 shares
$2,980,054
Significance 6/10

CFO Kovacs sells 103,822 shares ($3.0M) across 2 transactions; stock down 14.8% in 30 days amid $-42.2M annual loss

Kovacs Shane William Charles, Chief Operating & Financial Officer, executed 2 separate sales totaling 103,822 shares for $2,980,054.22, reducing his holdings by 42.6% from 243,549 to 139,727 shares. The transactions occurred at blended average price of $28.70, within the stock's recent downtrend: the current price of $29.19 reflects a 14.8% decline over the prior 30 days and sits 18.5% below the 52-week high of $35.83. The company reported net income of $-42,217,000.00 for its most recent full fiscal year, signaling ongoing unprofitability. A substantial near-half reduction in an executive's stake during deteriorating near-term price momentum warrants attention to company fundamentals and near-term outlook.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access